NIH-funded research R01 grant

Problems in specific brain cells linked to Fragile X symptoms

Official title: Cortical Interneuron Dysfunction in Fragile X Syndrome

Funded at University of California Los Angeles · NIH-11284007 · Data updated 2026-11-12

This research looks at whether problems with certain brain cells called parvalbumin interneurons lead to sensory sensitivity in people with Fragile X Syndrome.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$485,966
NIH project number5R01HD108370-05
Project IDNIH-11284007 on NIH RePORTER

Who could benefit from this research

Could help

People with Fragile X Syndrome—especially those who experience sensory hypersensitivity—are the population most likely to benefit from eventual therapies informed by this work.

Less likely to help

People without Fragile X Syndrome or whose symptoms are unrelated to sensory processing are unlikely to benefit directly from this project in the near term.

What this research studies

Researchers use a well-established Fragile X mouse model to trace how parvalbumin interneurons are born, migrate, mature, and connect into the sensory cortex. They combine birth-dating, anatomy, two-photon and functional recordings, and repetitive sensory (whisker) stimulation to link cellular changes to tactile defensiveness. The team also tests whether briefly boosting interneuron activity can correct circuit dysfunction and reduce maladaptive avoidance behaviors in mice. Findings aim to point toward cellular targets that could guide future human treatments.

Why it matters

Potential benefit: If successful, this work could point to new therapies that target interneurons to reduce sensory hypersensitivity in people with Fragile X Syndrome.

How similar studies have gone: Previous mouse studies have shown that restoring interneuron activity can improve sensory circuit function, but translating those approaches to safe and effective human treatments remains unproven.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Portera-Cailliau, Carlos — University of California Los Angeles
  • Study coordinator: Portera-Cailliau, Carlos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.